Sunshine Biopharma, Inc.
Market Cap
$5.45M
P/E Ratio
0.21
EPS
$5.31
Dividend Yield
0.00%
52-Week Range
$1.05 — $3.90
Volume
5.16K
Avg Volume
43.17K
Beta
1.64
P/E (TTM)
0.21
Forward P/E
—
PEG Ratio
-0.11
P/S (TTM)
0.14
P/B (TTM)
0.21
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.25%
ROA (TTM)
-0.19%
ROIC
—
Gross Margin
0.33%
Operating Margin
-0.17%
Net Margin
—
Debt/Equity
0.04
Current Ratio
4.20
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.84%
EPS Growth (5Y)
+0.26%
Sales Growth (3Y)
+7.67%
Sales Growth (5Y)
+5.52%
EPS Est (This Year)
$-0.32
EPS Est (Next Year)
—
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$2.00
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
4.91M
Float
4.90M
Free Float %
99.96%
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
CA
Exchange
NASDAQ
IPO Date
2022-02-15
Employees
52
CEO
Steve N. Slilaty
Index Membership
—
Website
https://www.sunshinebiopharma.com
Sunshine Biopharma, Inc. (SBFM) is a healthcare company in the drug manufacturers - specialty & generic industry listed on the NASDAQ. With a market capitalization of $5.45M, a P/E ratio of 0.21, SBFM is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare SBFM against other stocks using dozens of fundamental and technical filters.
DHB.V
Delivra Health Brands Inc.
$0.19
+0.00%
$5.94M
HASH.V
Simply Solventless Concentrates
$0.06
+37.50%
$6.35M
PCLO.V
PharmaCielo Ltd.
$0.07
+7.69%
$13.16M
SNOA
Sonoma Pharmaceuticals, Inc.
$2.40
+0.00%
$4.15M
SXTC
China SXT Pharmaceuticals, Inc.
$1.80
+1.12%
$1.54M
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
$1.03
+0.98%
$1.10M
Sunshine Biopharma, Inc. (SBFM) has a trailing twelve-month (TTM) P/E ratio of 0.21. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Sunshine Biopharma, Inc. (SBFM) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Sunshine Biopharma, Inc. (SBFM) has a market capitalization of $5.45 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.